Century Therapeutics Statistics
NASDAQ: IPSCHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
1.28-0.04 (-3.03%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Century Therapeutics by the numbers
Century Therapeutics has a market capitalization of $231.8 million based on 181.08M shares outstanding. With trailing EPS of $-0.93, Century Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 33.7% below its 50-day average and 38.4% below its 200-day average.
Average daily trading volume is 658.60K shares, or about $843,008 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
IPSC valuation vs. peer median
| Metric | IPSC | Peer median | Difference |
|---|---|---|---|
| Market cap | $231.78M | $229.00M | +1% |
| Avg. volume | 658.60K | 1.52M | -57% |
Peer median across 8 companies: LCTX, STRO, PLX, IVVD, ALEC, FATE, PALI, CGEN.
Valuation
- Market cap
- $231.78M
- EPS (TTM)
- $-0.93
- Shares outstanding
- 181.08M
Price and trading
- Previous close
- 1.32
- Open
- 1.29
- Day range
- 1.27 – 1.32
- 52-week range
- 0.435 – 3.04
- 52-week change
- +128.98%
- Beta
- —
- Volume
- 697.24K
- Average volume
- 658.60K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 12, 2026
Additional statistics
- Market Cap
- 231.78M
- Forward Pe
- -2.84
- Eps
- -0.93
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.04
- Week52 Low
- 0.44
- Avg Volume
- 658.60K
- Shares Outstanding
- 181.08M
- Ma50
- 1.93
- Ma200
- 2.08
- Earnings Date
- Aug 12, 2026
- Pct From52w High
- -57.89%
- Pct From52w Low
- 194.25%